Psychosocial adaptation and quality of life among Brazilian patients with different hematological malignancies

Santos, Fábio R. M. dos; Kozasa, Elisa Harumi; Chauffaille, Maria de Lourdes L.F.; Colleoni, Gisele W. B.; Leite, José Roberto

doi:10.1016/j.jpsychores.2005.08.017

Cited by 57 publications

(78 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Santos et al indicated that patients with leukemia, like other patients with hematologic malignancy, have low quality of life (7). Results of the studies of Andrade and Nabaee' (2013) on patients with leukemia reflected that they had low quality of life (8,22).…”

Section: Discussionmentioning

confidence: 99%

“…During a study, quality of life of patients with different blood malignancies were compared, and it was reported that patients with leukemia had a low quality of life (7). In addition, a study by Andrad on patients with leukemia, who were under chemotherapy in Brazil in 2013, reflected that mean quality of life was low in social, cognitive and psychological function aspects (8).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Effect of Family-Centered Empowerment Model on the Quality of Life of Patients with Leukemia

Davarpanah

Fayazi

Shariati

et al. 2016

Jundishapur J Chronic Dis Care

View full text Add to dashboard Cite

Background: Leukemia is a common cancer among adults with growing prevalence in Iran. This disease affects different aspects of the patient, especially their quality of life. One of the methods to promote hygiene and health and, consequently, quality of life is to empower the family of the patient. Objectives: The effect of family-based empowerment on quality of life in patients with leukemia was studied in this research. Methods: This study was a clinical trial conducted on 46 adult patients with leukemia together with 46 of their family members in 2015. Eligible patients were selected by the available method and randomly placed in two groups of test and control. Tools for gathering data included a demographic questionnaire about the patient and their family member and a specified questionnaire about the quality of life of patients with cancer. Family-based empowerment intervention was held for research samples in the test group based on its quadruple steps (perceived threat, self-efficiency promotion, increase of self-esteem through educational participation, and assessment) in six 90-minute sessions and a second test was conducted a month and half after the intervention. Data were analyzed using the SPSS 20 statistical software. Results: Results of chi-square test reflected that both groups of test and control were similar in terms of demographic information (P > 0.5). Moreover, statistical independent T-test did not show a significant difference in aspects of quality of life in test and control groups before the intervention (P = 0.98) while this test showed a significant difference in both groups after the intervention (P = 0.00), except for the spiritual aspect (p=0.2). Paired T-test indicated a significant increase in aspects of quality of life in the test group after the intervention (p=0.00) while this test reflected a reverse significant difference in general aspect of quality of life in the control group (P = 0.006). Conclusions:In general, results of this research showed that implementing family-based empowerment pattern has been effective for increasing quality of life in patients with leukemia.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The Effect of Family-Centered Empowerment Model on the Quality of Life of Patients with Leukemia

Davarpanah

Fayazi

Shariati

et al. 2016

Jundishapur J Chronic Dis Care

View full text Add to dashboard Cite

show abstract

“…Such information for patients in South America is timely, particularly in Brazil, with a population of almost 210-million people experiencing a 500% increase in cancer incidence between 1995 and 2015 [19]. To date, the few studies conducted in Brazil have found that 21 to 39% of cancer patients displayed clinical levels of anxiety, and from 17 to 47% endorse depression [20][21][22]. However, these studies have substantial methodological limitations, such as use of cross-sectional design [20][21][22] and convenience sampling without specific eligibility criteria based on the time since diagnosis and treatment type or status [22,24].…”

Section: Introductionmentioning

confidence: 99%

“…To date, the few studies conducted in Brazil have found that 21 to 39% of cancer patients displayed clinical levels of anxiety, and from 17 to 47% endorse depression [20][21][22]. However, these studies have substantial methodological limitations, such as use of cross-sectional design [20][21][22] and convenience sampling without specific eligibility criteria based on the time since diagnosis and treatment type or status [22,24]. These limitations also preclude reliable, precise knowledge on the prevalence, trajectory, and predictors of distress and problems in daily living among newly diagnosed cancer patients in Brazil.…”

Section: Introductionmentioning

confidence: 99%

A prospective study of changes in anxiety, depression, and problems in living during chemotherapy treatments: effects of age and gender

Bergerot

Mitchell

Ashing

et al. 2017

Support Care Cancer

View full text Add to dashboard Cite

Purpose Monitoring distress assessment in cancer patients during the treatment phase is a component of good quality care practice. Yet, there is a dearth of prospective studies examining distress. In an attempt to begin filling this gap and inform clinical practice, we conducted a prospective, longitudinal study examining changes in distress (anxiety, depression, and problems in living) by age and gender and the roles of age and gender in predicting distress. Methods Newly diagnosed Brazilian cancer patients (N = 548) were assessed at three time points during chemotherapy. Age and gender were identified on the first day of chemotherapy (T1); anxiety, depression, and problems in living were self-reported at T1, the planned midway point (T2), and the last day of chemotherapy (T3). Results At T1, 37 and 17% of patients reported clinically significant levels of anxiety and depression, respectively. At T3, the prevalence was reduced to 4.6% for anxiety and 5.1% for depression (p < .001). Patients 40-55 years, across all time points, reported greater anxiety and practical problems than patients >70 years (p < .03). Female patients reported greater emotional, physical, and family problems than their male counterparts (p < .04).Conclusions For most patients, elevated levels of distress noted in the beginning of treatment subsided by the time of treatment completion. However, middle-aged and female patients continued to report heightened distress. Evidence-based psychosocial intervention offered to at risk patients during early phases of the treatment may provide distress relief and improve outcomes over the illness trajectory while preventing psychosocial and physical morbidity due to untreated chronic distress.

show abstract

“…They cited needs such as chronic pain, depression, and other co-morbidities, complicated by limited financial resources and lack of medical coverage. Santos, Kozasa, Charffailleb, Colleoni, & Leite (2006) studied the prevalence of post-traumatic stress disorder in a group of patients with hematological malignancies in Brazil. The researchers found patients with multiple myeloma had the lowest quality-of-life scores in the physical functioning subscale.…”

Section: Introductionmentioning

confidence: 99%

Multiple myeloma: The patient’s perspective

Vlossak¹,

Fitch²

2008

CONJ

View full text Add to dashboard Cite

show abstract

Psychosocial adaptation and quality of life among Brazilian patients with different hematological malignancies

Cited by 57 publications

References 21 publications

The Effect of Family-Centered Empowerment Model on the Quality of Life of Patients with Leukemia

The Effect of Family-Centered Empowerment Model on the Quality of Life of Patients with Leukemia

A prospective study of changes in anxiety, depression, and problems in living during chemotherapy treatments: effects of age and gender

Multiple myeloma: The patient’s perspective

Contact Info

Product

Resources

About